CRA Madrid – Regional Monitoring

Resourcing Life Science; Comunidad de Madrid; Presencial; EUR 35.000 - 55.000; Jornada completa

Descripción de la vacante

An established industry player is seeking a dedicated Clinical Research Associate for regional monitoring in Madrid. This role involves overseeing clinical studies in phases II-III, ensuring compliance with Good Clinical Practices, and supporting investigators throughout the study process. If you have a passion for life sciences and a commitment to excellence in clinical research, this opportunity offers a chance to make a significant impact in a dynamic environment. Join a global CRO that values innovation and quality in supporting pharmaceutical and biotech companies worldwide.

Formación

• 1+ years of CRA monitoring experience in a CRO or pharmaceutical company.
• Strong understanding of Good Clinical Practices and compliance.

Responsabilidades

• Monitor clinical studies in phases II-III ensuring compliance with GCP.
• Identify and initiate investigators and their sites.

Conocimientos

Monitoring clinical studies

Good Clinical Practices (GCP)

Site initiation

Site close-out

Commercial studies

Educación

Bachelor's degree in life sciences

Descripción del empleo

Our client is a global CRO supporting various pharmaceutical and biotech companies worldwide. They offer comprehensive services including clinical and non-clinical development, peri-approval, and market access. They are currently seeking a CRA / Clinical Research Associate - Regional Monitoring in Madrid.

Job Overview

1. Monitoring clinical studies in phases II-III.
2. Ensuring adherence to Good Clinical Practices, investigator integrity, and compliance with all study procedures.
3. Identifying, qualifying, and initiating investigators and their sites.
4. Supervising study conduct according to GCP requirements and all applicable laws.

Key Requirements

1. Bachelor's degree in life sciences.
2. Minimum 1 year monitoring experience as a CRA within a CRO, pharmaceutical, or biotech company in the Netherlands.
3. Experience in commercial studies.
4. Experience with site initiation and site close-out.
5. Experience in clinical studies phase II-III.